Red Hat Ansible Tower up to 2.0.1 next_run cross site scripting
CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
---|---|---|
3.9 | $0-$5k | 0.00 |
A vulnerability, which was classified as problematic, has been found in Red Hat Ansible Tower up to 2.0.1. Affected by this issue is an unknown code. The manipulation of the argument next_run
with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity. CVE summarizes:
Multiple cross-site scripting (XSS) vulnerabilities in Ansible Tower (aka Ansible UI) before 2.0.5 allow remote attackers to inject arbitrary web script or HTML via the (1) order_by parameter to credentials/, (2) inventories/, (3) projects/, or (4) users/3/permissions/ in api/v1/ or the (5) next_run parameter to api/v1/schedules/.
The weakness was shared 01/27/2015 with SEC Consult Vulnerability Lab (Website). The advisory is shared for download at sec-consult.com. This vulnerability is handled as CVE-2015-1368 since 01/27/2015. The attack may be launched remotely. No form of authentication is required for exploitation. Successful exploitation requires user interaction by the victim. Technical details as well as a public exploit are known. The MITRE ATT&CK project declares the attack technique as T1059.007.
A public exploit has been developed by SEC Consult and been published before and not just after the advisory. The exploit is available at exploit-db.com. It is declared as proof-of-concept. The vulnerability was handled as a non-public zero-day exploit for at least 13 days. During that time the estimated underground price was around $5k-$25k.
Upgrading to version 2.0.2 eliminates this vulnerability.
The vulnerability is also documented in the databases at X-Force (99924) and Exploit-DB (35786). The entries 73890 and 73889 are related to this item.
Product
Vendor
Name
Version
License
CPE 2.3
CPE 2.2
CVSSv4
VulDB CVSS-B Score: 🔍VulDB CVSS-BT Score: 🔍
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 4.3VulDB Meta Temp Score: 3.9
VulDB Base Score: 4.3
VulDB Temp Score: 3.9
VulDB Vector: 🔍
VulDB Reliability: 🔍
CVSSv2
AV | AC | Au | C | I | A |
---|---|---|---|---|---|
💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
---|---|---|---|---|---|
unlock | unlock | unlock | unlock | unlock | unlock |
unlock | unlock | unlock | unlock | unlock | unlock |
unlock | unlock | unlock | unlock | unlock | unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-74 / CWE-707
CAPEC: 🔍
ATT&CK: 🔍
Local: No
Remote: Yes
Availability: 🔍
Access: Public
Status: Proof-of-Concept
Author: SEC Consult
Download: 🔍
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
0-Day | unlock | unlock | unlock | unlock |
---|---|---|---|---|
Today | unlock | unlock | unlock | unlock |
Exploit-DB: 🔍
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: UpgradeStatus: 🔍
0-Day Time: 🔍
Upgrade: Ansible Tower 2.0.2
Timeline
01/13/2015 🔍01/14/2015 🔍
01/14/2015 🔍
01/14/2015 🔍
01/27/2015 🔍
01/27/2015 🔍
01/27/2015 🔍
02/08/2015 🔍
03/27/2015 🔍
08/22/2022 🔍
Sources
Vendor: redhat.comAdvisory: 129944
Organization: SEC Consult Vulnerability Lab
Status: Not defined
CVE: CVE-2015-1368 (🔍)
X-Force: 99924
Vulnerability Center: 48510 - Ansible Tower <2.0.5 Multiple Remote XSS Vulnerabilities, Medium
SecurityFocus: 72023 - Ansible Tower Multiple Cross Site Scripting Vulnerabilities
OSVDB: 116961
scip Labs: https://www.scip.ch/en/?labs.20161013
See also: 🔍
Entry
Created: 03/27/2015 14:56Updated: 08/22/2022 09:35
Changes: 03/27/2015 14:56 (58), 06/19/2017 08:39 (12), 04/12/2022 08:22 (3), 08/22/2022 09:35 (3)
Complete: 🔍
No comments yet. Languages: en.
Please log in to comment.